P&T Committee Meeting Information
Upcoming Meetings
Dates
- Register for Wednesday, September 24, 2025 - from: 12:00pm-4:00pm
- Register for Thursday, September 25, 2025 - from: 9:00am-4:00pm
Location
- The September P&T Committee meetings will be held virtually.
Public Testimony
- All members of the public may register to provide verbal or written testimony related to a drug or class of drugs included on the Statewide PDL at the P&T Committee meetings.
- Registration to present testimony during the meetings must be received by Tuesday, September 2, 2025. To register, please go to the Pennsylvania Medical Assistance Preferred Drug List website and select "Public Testimony Registration." Please include the drug or class of drugs you wish to speak on. You will receive a confirmation email for your public testimony registration, which will be a separate from the email containing your webinar registration details.
- Written testimony will be accepted and must be submitted by Tuesday, September 2, 2025. The written testimony will be distributed to all P&T Committee members prior to the meetings. Written testimony should be emailed to RA-PharmForms@pa.gov. You will receive a confirmation email that your written testimony has been received.
The list of drug lasses to be reviewed will be posted prior to the meeting.
- Past Pharmacy and Therapeutics Committee Meetings
- Review the Pharmacy and Therapeutics Committee By-Laws
Related Links
The Department of Human Services (Department) appointed the P&T Committee to act in an advisory capacity to the Department and the Office of Medical Assistance Programs (OMAP) and provide an unbiased clinical perspective on the Department's Statewide Preferred Drug List (PDL). Recommendations from the committee must be reviewed and approved by the Secretary of the Department of Human Services.
Change Healthcare provides clinical and financial analysis support to the P&T Committee.
Committee Information
Composition and responsibilities of the committee:
- Comprised of department medical directors, external physicians, pharmacists, consumer advocates, and specialists as needed for drug class reviews.
- Recommend a clinically-based PDL with an emphasis on effectiveness, safety, and outcomes.
- Recommend prior authorization guidelines for non-preferred drugs as well as certain preferred drugs using current community standards for prescribing.
- Recommend Prospective and Retrospective Drug Utilization Review Program Review and Development.
Name | Specialty | Independent* | Department** | MCO |
---|---|---|---|---|
Ivonne Acrich, MD | OMHSAS Child/Adolescent Psychiatrist |
| X |
|
Dale Adair, MD, FAPA | Office of Mental Health & Substance Abuse Services Medical Director | | X | |
Christopher Antypas, PharmD | Community Pharmacist | X |
|
|
Lawrence Appel, MD, SFHM | Medical Director, Office of Long Term Living |
| X |
|
Terri Cathers, PharmD, | OMAP Pharmacy Director |
| X |
|
Michael Colvin, PharmD | AmeriHealth Caritas & Keystone First HealthChoices & Community HealthChoices Pharmacist | | | X |
Sharon Connor, PharmD | Academic Pharmacist | X |
|
|
Molly DiMatteo, DO | Family Practitioner | X | | |
Oluwatoyin Fadeyibi, PharmD, MPH | Community Behavioral Health Pharmacist | | | X |
Andrea Fox, MD | Internist | X |
|
|
Mark Fuller, MD | Carelon Health of PA Medical Director | X | ||
Donald Gerhart, RPh | Community Pharmacist | X |
|
|
James Hancovsky, RPh, MBA | United Health Care Pharmacy Director |
|
| X |
Van Hellerslia, PharmD, BCPS | Consumer Representative | X | ||
David Kelley, MD | OMAP Chief Medical Officer, Office of Medical Assistance Programs | | X | |
Chen Kenyon, MD, MSHP | Pediatrician | X | ||
Peter Kreckel, RPh | Community Pharmacist | X |
|
|
Renee Licwinko, RPh | Gateway Health Plan Pharmacist |
|
| X |
Michele Musheno, RPh, MS | Academic/Hospital Pharmacist | X |
|
|
Geoffrey Neimark, MD | Community Care Behavioral Health Psychiatrist | | | X |
Ian Paul, MD, Vice Chair | Pediatrician | X |
|
|
Adam Raphael Rom, MD | Family Practitioner | X |
|
|
Amy Saracino, DO | OMHSAS Adult Psychiatrist |
| X |
|
John Shand, MD | PerformCare PA Medical Director | X | ||
Jason Skaria, PharmD | PA Health & Wellness Pharmacist | X | ||
Christopher Squillaro, DO | Magellan Behavioral Health of PA Medical Director | | | X |
Kevin Szczecina, RPh | Geisinger Health Plan Pharmacist |
|
| X |
Fallan Vaisberg, PharmD, RPh | Health Partners Plans Formulary Pharmacist | | | X |
Andreas Wali, MD | Cardiologist | X | | |
Verlyn Warrington, MD | Bariatric Medicine Specialist/Family Medicine Doctor | X |
|
|
Lloyd Wertz | Consumer/Family Advocate | X |
|
|
Lauren Zandier, PharmD | UPMC For You Pharmacist | | | X |
* - Independent Members are not employed by the Department
** - Department Members are employed by the Department on a full or part-time basis
Effective December 6, 2024 / Last modified January 8, 2025